Xenon Pharmaceuticals shares fell 27.5% in pre-market trading after the company paused recruitment of new patients for its antidepressant drug trial.

2026-09-18

Xenon Pharmaceuticals shares fell 27.5% in pre-market trading after the company paused recruitment of new patients for its antidepressant drug trial.